(Q40767774)

23 September 2017

The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. (English)

1 reference

23 September 2017

Maria Vivo

4

0 references

Viola Calabrò

object named as

Viola Calabrò

1

0 references

Raffaele A. Calogero

object named as

Raffaele A Calogero

5

0 references

author name string

Gelsomina Mansueto

2

1 reference

23 September 2017

Tiziana Parisi

3

1 reference

23 September 2017

Girolama La Mantia

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

19 November 2001

1 reference

Journal of Biological Chemistry

23 September 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

277

1 reference

23 September 2017

2674-2681

1 reference

23 September 2017

4

1 reference

The p53 family: same response, different signals?

23 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Regulation and function of the p53-related proteins: same family, different rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Cloning and functional analysis of human p51, which structurally and functionally resembles p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

The yeast two-hybrid system reveals no interaction between p73 alpha and SV40 large T-antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

p63 is a p53 homologue required for limb and epidermal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

MDM2 suppresses p73 function without promoting p73 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Suppression of Ras-mediated NIH3T3 transformation by p19ARF does not involve alterations of cell growth properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Identification of a sequence element from p53 that signals for Mdm2-targeted degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Regulation of p63 function by Mdm2 and MdmX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

P63 and P73: P53 mimics, menaces and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

Mdm2 binds p73 alpha without targeting degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

MDM2 and MDMX bind and stabilize the p53-related protein p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

21 January 2018

MDM2: life without p53.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

MDM2--master regulator of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

p63 and p73 transactivate differentiation gene promoters in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M107173200

21 January 2018

Identifiers

DOI

10.1074/JBC.M107173200

1 reference

23 September 2017

1 reference